Biogen Inc. buy Needham & Company LLC
Start price
30.10.24
/
50%
€166.70
Target price
30.10.25
€248.94
Performance (%)
-22.98%
End price
31.10.25
€128.40
Summary
This prediction ended on 31.10.25 with a price of €128.40. The price of Biogen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -22.98%. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -4.751% | -4.751% | -0.034% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by Needham___Company_LL for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $270.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten